Experience

Bio Delivery Sciences Intl

• United States
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Territory Manager

  • Jan 2022 - Present

  Selected to be part of the inaugural BDSI sales team to introduce a novel migraine medication to Neurologists; the first and only COX-2 inhibitor formulated as a fast-acting, ready-to-use oral solution for the acute treatment of migraine. Selected to be part of the inaugural BDSI sales team to introduce a novel migraine medication to Neurologists; the first and only COX-2 inhibitor formulated as a fast-acting, ready-to-use oral solution for the acute treatment of migraine.



Esperion

• United States
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Pharmaceutical Sales Specialist

  • Mar 2020 - Dec 2021

  • Recognized by Regional Sales Manager and peers with team collaboration award • Call on Cardiologists, Endocrinologists, PCPs, as well as MGH, Lahey Clinic, MetroWest Medical Center • Launched products in challenging COVID-19 period; utilized vast experience to create access by implementing both live and virtual tactics to increase sales in the Boston market place • Gained sales momentum through identification of prescribing habits, data analysis and strong knowledge of territory • Aligned with market access team to assist with pull through; utilizing specialty pharmacies, co-pay cards and assisting accounts with the prior authorization process that led to a 70% approval rate of prescriptions • Worked with Walgreens Community Pharmacy, CVS Caremark, ASPN HUB environment to help offices triage prescriptions to ensure coverage and to ensure the patients receive their prescription • Secured 25% growth in NRX’s; recognized with national award - “Summer Sizzle Contest” - an NRX contest award Show less



Amgen

• United States
• Biotechnology Research
• 700 & Above Employee

• Senior Biopharmaceutical Representative

  • Mar 2018 - Oct 2021

  Provide current and comprehensive clinical knowledge of Amgen's PCSK9 Repatha, an injectable human monoclonal antiboby designed for the treatment of hyperlipidemia. Provide current and comprehensive clinical knowledge of Amgen's PCSK9 Repatha, an injectable human monoclonal antiboby designed for the treatment of hyperlipidemia.



Bayer Pharmaceuticals

• Pharmaceutical Manufacturing
• 700 & Above Employee

• Pharmaceutical Sales Specialist | Rare Disease

  • Sep 2014 - Mar 2018

  • Internally recruited to sell Adempas which is used to treat patients with the rare diseases of chronic thromboembolic pulmonary hypertension (WHO Group 4) and pulmonary arterial hypertension (WHO Group 1) • Mapped out patient referral network, identified key Cardiologists and Pulmonologists, and developed patient acquisitions plans• Delivered new prescriptions of 101% to plan over two years, increasing new enrollments by 60% and more than doubling the number of patients on the drug; Received Gold Award in 2017 for going above and beyond Show less

• Senior Sales Consultant/ Xarelto, CardioPulmonary Division

  • Nov 2013 - Aug 2014

  • Selected for Bayer’s first Sales Division in the CardioPulmonary market place• Called on Cardiologists for Atrial Fibrillation, DVT’s and PE’s including those at Boston teaching hospitals• Gained access to key Cardiologists previously thought of as ‘no-sees”• Recognized as National Winner “X2K” – Total NBRX Market Share Change & Total NBRX Market Share



Quintiles

• Spain

• Cardiovascular Specialty Sales Representative

  • Jan 2012 - Oct 2013

  Quintiles was contracted by Janssen to promote Xarelto, a novel anti-coagulant for the treatment of atrial fibrillation. • Ranked 20 out of 90 at the end of Q3 2013, a 60-place improvement from starting rank of 85 out of 90 • Finished in the Top 5 in the country for “Lead the Way” contest in increasing new Rx share Quintiles was contracted by Janssen to promote Xarelto, a novel anti-coagulant for the treatment of atrial fibrillation. • Ranked 20 out of 90 at the end of Q3 2013, a 60-place improvement from starting rank of 85 out of 90 • Finished in the Top 5 in the country for “Lead the Way” contest in increasing new Rx share



Pallimed Solutions Pharmacy, Woburn, Ma.

• Director of New Business Development for Specialty Pharmacy

  • Mar 2010 - Dec 2011

  Pallimed was a specialty compounding pharmacy. • Called on Urologists, OB/GYN, Internists and Gastroenterologists throughout New England • Led major sales efforts which resulted in 20% increase in revenue overall, and specifically increased sales of intracavemosal injectable therapies for erectile dysfunction by 20% within a year • Developed a strategic marketing initiative to expand use of a high value testosterone gel Pallimed was a specialty compounding pharmacy. • Called on Urologists, OB/GYN, Internists and Gastroenterologists throughout New England • Led major sales efforts which resulted in 20% increase in revenue overall, and specifically increased sales of intracavemosal injectable therapies for erectile dysfunction by 20% within a year • Developed a strategic marketing initiative to expand use of a high value testosterone gel



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Professional Sales Representative, MSP Joint Venture, Boston

  • Jan 2008 - Feb 2010

  • Exceeded sales objectives in the Lipid Franchise including arresting market share erosion and increasing market share growth; three-time winner of Merck’s national “Rise to the Challenge” incentive program as a result. • Member of Merck’s elite Senior Executive Council.

• Senior Professional Sales Representative, USHH Boston

  • Jun 2005 - Dec 2007

  • Generated almost $10mm in sales for Osteoporosis (Fosamax) and Asthma (Singular) contributing to the District achieving market share ranking of 2nd nationally for Fosamax among all Merck Districts* Conducted extensive business analysis and implemented targeted activities for non formulary products within highly segmented market.

• Senior Professional Dermatology Representative

  • Jan 2003 - May 2005

  • Successfully reversed declining prescription trend of Propecia resulting in sales of $1.7mm. • Executed an aggressive market expansion strategy focused on increased activities within Boston’s teaching hospitals.

• Professional Sales Representative, USHH

  • Jun 1991 - Dec 2002

  • Recipient of Merck’s prestigious VP Club Award in 2000 for sales ranked in the Top 5% of the nation.• Created and implemented marketing campaign for 2 Cardiopulmonary Rehabilitation Clinics as well as doing numerous public outreach educational programs for "Women and Heart Disease"